Bright Green Corporation is breaking new ground in domestic production of plant-based medicines in the United States. Committed to sustainable high-tech agriculture, manufacturing, and research—a foundation built from a legacy of cannabis expertise and operations— Bright Green is a federally-authorized manufacturer of Active Pharmaceutical Ingredients (APIs) and plant-based drugs. With substantial ongoing support from the U.S. Congress to reduce reliance on foreign imports, Bright Green is at the forefron
Our Mission As operations expand at Bright Green’s 1 million sq ft Grants, New Mexico Facility to concentrate on the research, production, manufacture, and distribution of APIs, plant-based drugs, and Cannabis, compliance remains a key part of its ethos. Enabled by a New Mexico Board of Pharmacy application, and operating in full alignment with federal regulations including obtaining DEA registrations for new controlled substances, Bright Green has quickly emerged as a leader in the USD $27.97 Billion globa
As the sole business of this scale capable of meeting market demand, Bright Green is dedicated to securing long-term federal government contracts to establish a reliable domestic API supply chain, helping to diminish U.S. dependency on foreign drug imports and deliver exceptional value to shareholders.